Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.

ABSTRACT:

SUBMITTER: Dayan GH 

PROVIDER: S-EPMC10626161 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature